Stocklytics Platform
Asset logo for symbol TSVT
2seventy bio
TSVT60
$4.990.00%$0.00
Penny Stock
Asset logo for symbol TSVT
TSVT60

$4.99

0.00%
Key Stats
Open$4.98
Prev. Close$4.99
EPS-1.83
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$260.12M
PE Ratio-
LOWHIGH
Day Range4.97
4.98
52 Week Range1.53
6.40
Ratios
EPS-1.83
Fundamentals
Payout Ratio-
Industry average yield2.87%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

TSVT-
US Healthcare Sector-
US Market-
warning

TSVT / Market

TSVT lose to the US Market which returned 2.57% over the last twenty four hours.
warning

TSVT / Healthcare Sector

TSVT lose to the US Healthcare sector which returned 3.48% over the last twenty four hours.

2seventy bio (TSVT) Statistics

2seventy bio, Inc. (TSVT) is a biotechnology company that specializes in the development of novel therapies for the treatment of various diseases. The company is focused on leveraging its expertise in molecular biology and genomics to identify potential drug targets and develop innovative therapies. With a strong pipeline and a talented team of researchers, 2seventy bio is well-positioned to make a significant impact in the field of biotechnology.
2seventy bio, Inc. (TSVT) has been making waves in the biotech industry with its impressive valuation metrics. The company's strong fundamentals and innovative approach have led to a high valuation, making it an attractive investment option for many investors. With a solid stock performance compared to its sector, 2seventy bio is poised for continued success.
add 2seventy bio to watchlist

Keep an eye on 2seventy bio

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has 2seventy bio (TSVT) stock's performance compared to its sector and the market over the past year?

Over the past year, 2seventy bio (TSVT) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 20.77%, 2seventy bio has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 36.14%, it has fallen short of the market average. This comparison highlights 2seventy bio's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of 2seventy bio (TSVT) stock?

The PE ratio for 2seventy bio (TSVT) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of 2seventy bio (TSVT) stock?

The Earnings Per Share (EPS) for 2seventy bio (TSVT), calculated on a diluted basis, is -$1.83. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of 2seventy bio (TSVT) stock?

The operating margin for 2seventy bio (TSVT) is -99.29%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of 2seventy bio (TSVT) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of 2seventy bio (TSVT) is -$133.86M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does 2seventy bio (TSVT) have?

2seventy bio (TSVT) has a total debt of $247.45M. The net debt, which accounts for cash and cash equivalents against the total debt, is $187.46M.

Take Your Investments to a Whole New Level